Lifecore Biomedical, Inc. (LFCR)
3.77
-0.10
(-2.58%)
USD |
NASDAQ |
Mar 27, 11:30
Lifecore Biomedical Cash from Investing (Quarterly) : 8.041M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Integer Holdings Corp. | -35.47M |
| Molina Healthcare, Inc. | 230.00M |
| Cytokinetics, Inc. | -71.19M |
| Inspire Medical Systems, Inc. | -11.92M |
| CytomX Therapeutics, Inc. | -14.42M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.568M |
| Cash from Financing (Quarterly) | -3.042M |
| Free Cash Flow | 2.628M |
| Free Cash Flow Per Share (Quarterly) | 0.0963 |
| Free Cash Flow to Equity (Quarterly) | -2.593M |
| Free Cash Flow to Firm (Quarterly) | 13.08M |
| Free Cash Flow Yield | 1.87% |